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Medical Staff

Progress Notes
From the
President
We continue to
proceed in an accelerated mode to
develop our managed care structure.
As you are all aware, the General
Medical Staff, at a special meeting on
January 18, unanimously approved
development of a business plan. I have
been in contact with Dan Grauman,
our Raleigh Consultant, and a work
plan is being developed. I plan to
dis~uss this with him in the next week
and, hopefully, soon thereafter call a
meeting of our Strategic Development
Committee to continue work on our
business plan.
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We have attempted to improve our
committee structure for the Medical
Staff. Specifically, Allied Health has
been deleted and its function will be
taken over by the Credentials
Committee. The Credentials
Committee itself has been restructured
and will now be chaired by the
immediate Past President of the
Medical Staff enabling· direct feedback
to the Medical Executive Committee
and the Board of Trustees. Also, the
Clinical Chairmen will be voting
members of the Credentials
Committee. Seven at-large members
from the Medical Staff will serve on
this committee.

Volume 5, Number 2
February, 1993

The Quality Assurance Committee has
also been empowered to address our
quality concerns and bring us to a level
of true quality rather than meeting
minimal standards. The Occurrence
Analysis Committee, Procedural Case
Review Committee, Transfusion
Committee, and Utilization Review
Committee now all report to the
Quality Assurance Committee of the
Medical Staff. The Continuing
Medical Education Committee has been
asked to develop educational programs
tied directly to quality assurance
problems. Graduate Medical
Education and the Nutrition Committee
are now hospital committees.
At the Medical Executive Committee
meeting in February, Richard Fleming,
member of the Board of Trustees,
presented the Ad Hoc Committee
report of the Board on the Clinical
Department Chairperson Review Panel.
The Medical Executive Committee will
be reviewing this and providing followup to the Board of Trustees via its
leadership. Any interested members of
the Medical Staff may review the
report which is available in the
Medical Staff Services Office. Your
comments will be appreciated and they
can be forwarded to me, John
Castaldo, M.D., or John Jaffe, M.D.
Continued on Page 2
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Next month, Rev. Dr. Grant Harrity,
member of the Board of Trustees, will
attend the Medical Executive
Committee to discuss the Ad Hoc
Board report on Education.
A Search Committee for the Chief of
Clinical. Services has met, and a
consultant, Dr. Joseph Lindner (former
Chief of Medicine at St. Barnabus),
has been hired to facilitate the search
process. Applications will be accepted
from outside the organization as well
as internally. Applications, along with
current resumes, should be forwarded
to the Office of the President,
Attention: Gina Jones.

Outpatient Rehabilitation
Outpatient Rehabilitation Services,
located in Suite 307 of 1251 S. Cedar
Crest Boulevard, has added a new
modality in their clinic. The modality,
called Iontophoresis, is a non-invasive
treatment alternative to molecular
Cortisone injections for the reduction
of soft tissue inflammation. The
modality is indicated in the trr..atment
of acute tissue inflammation ~ncluding
rotator cuff tendinitis, subacromial
bursitis, biceps tendinitis, medial .and
lateral epicondylitis, pes anserinus
bursitis, plantar fascitis, etc.
The modality utilizes the characteristics
of direct electrical current (DC) to
ionically drive negatively or positively
charged medications into the area of
inflammation. The new Iontophoresis
system offers specialized one time use
buffered electrodes to reduce the
incidence of bums and increase patient
comfort.

With Mr. Huston's resignation as
President and CEO, we, the memben
of the Medical Staff, must accept an
even greater responsibility to provide
clinical leadership to insure
uninterrupted high quality medical care
for our patients. I look forward to
your suggestions and assistance as we
continue to move forward.

Jf:.

Candio, M.D.
President, Medical Staff

Servi~es

Update

Treatments are 'typically performed
every other day to minimize skin
irritation from the direct ·current and to
take advantage of the carry-over effect
of the medication from the previous
treatment. For acute inflammation, a
typical protocol would consist of four
to six treatment sessions.
The outpatient clinic currently stocks
.4% Dexamethasone sodium phosphate.
When ordering this modality, the
referring physician should indicate on
the prescription "Iontophoresis .4%
Dexamethasone."
Please refer any questions regarding
this modality to Sharon Hix Duvall,
P.T., M.S., Director, Outpatient
Rehabilitation Services, at 402-1080.
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Laboratory
Update

Effective immediately, please do not
use the abbreviation T3RU for the test
Thyroid Binding Resin Uptake. If
you must use an ordering abbreviation,
please use TBI for Thyroid Binding
Index. Better yet, just order a 17, or
Thyroid Prof"de, and a T4 and TBI
will be done.
The problem with T3RU is that the
order is misread as T3RIA
(Triiodothyronine) which is expensive

Library
News

)

New book acquisitions in the Library
at 17th & Chew include:
Braunwald. Heart Disease. 4th ed.
J.B. Lippincott, 1992.

and does not provide the expected
clinical information. To further
address this problem, T3RIA is also
being redefined as Total-T3. If a
Triiodothyrine is referenced, please use
the abbreviation Total-T3 on your
request.
These changes will be reflected in both
the new Laboratory Handbook and the
revised Laboratory request forms.

The Library at Cedar Crest & 1-78 also
subscribes to the AMA Diagnostic and
Therapeutic Technology Assessment
reports.
"·....

'1-.•

Thompson. Telinde's Operative
Gynecologic Surgery. 7th ed. J .B.
Lippincott, 1992.
Wallach. Interpretation of Diagnostic
Tests. 5th ed. - Little, Brown, 1992.
In addition, the Library at 17th &

Chew subscribes to the AHA Hospital
Technology Series.
New book acquisitions at Cedar Crest
& 1-78 include:
Raz. Atlas of Transvaginal Surgery.
W.B. Saunders. 1992.
Dolecek. Endocrinology of Thermal
Trauma. Lea & Febiger. 1990.
Thoene. Physicians' Guide to Rare
Diseases. Dowden Publishing. 1992.

)
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Chart Order Update
In order to provide optimum quality
care to the patient and to benefit all
parties handling the medical. record
(physicians, nursing, unit clerks,
ancillary departments, Medical Record
department), the following changes
have been made in the chart order:
o During the period of time that the
chart is on the nursing unit and active,
the Do Not Resuscitate and Advanced
Directives forms will be placed on the
front of the Admission Section. After
discharge, these forms will be
incorporated into proper chart order.
o All consents will be placed in the
admission section of the chart after An
Important Message from Medicare.
o The Operative Report section will be
placed in front of the Progress Note
section, with all typed reports first.
o The Initial and Signature Record
will become the first sheet in the Flow
section.

The Medical Record Committee also
:equests your attention to the following ,
1ssues:
'
o The Emergency Department
Continuity of Care Record and Trauma
Resuscitation Sheet must be signed by
a physician. This is a JCAHO and
Pennsylvania Department of Health
requirement. In addition, third party
insurance companies could deny
payment to the hospital if these forms
are not signed. The Medical Record
Department will flag these forms if not
signed by the physician.
o It is the ultimate responsibility of the
physician to complete and sign the
Physician's section of the Patient
Transfer Form. Nursing homes will
return patients to the hospital if this
form is incomplete.
o When handwriting a consultation,
please remember to remove the
physician copy and take it back to yo~ou )
office. This will expedite your office's
billing procedure.

If you wish a copy of the new chart
order,. please contact Shirley Wentzel,
Coordmator, Medical Records, at
402-8330.

News from the Vascular Laboratory
Effective February 8, dictated results
may be retrieved for Transcranial
Dopplers through the present dictation
system available through Medical
Records Transcription by using two
digit work type 10.

If you have any questions, please
contact Alice Madden, R.N., Manager,
Vascular Laboratory, at 402-8821.

Page 4

New Administrative Directive Approved for
Pre-Printed Doctors Orders
In December, 1992, Administrative
Directive 4500.15 regarding PrePrinted Doctors Orders became
effective.
The policy, as written, states:
Pre-printed doctors orders and
therapies may be developed for
procedures by specific departments or
sections.
Requests for pre-printed doctors orders
shall be submitted for review and
acceptance by the Chairman of the
Department and Chief of the
Division/Section. Pre-printed doctors
order requests will be reviewed by the
Forms Committee only after
endorsement has been obtained.

Pre-printed doctors orders shall meet
the requirements established by
Clinical Nutrition Services, Laboratory
Services, Medical Records, Nursing
Services, Pharmacy, Radiology
Services, and Respiratory Services/
Pulmonary Laboratory. The
requirements have been accepted by the
Medical Records and Medical
Executive Committees.
A revised pre-printed doctors order
must also be approved, and meet the
established requirements.
This policy is available in its entirety
in the Administrative Policy Manual
which you may review in Medical Staff
Services.

)

Physician Volunteer Effort
A special Thank You to the physicians
who volunteered to serve on the phone
banks at public television stations
across the state during the January
broadcasts of Breaking the Cycle of
Domestic Violence.
The one-hour special was supported by
the Pennsylvania Medical Society, its
Auxiliary, and the Educational and
Scientific Trust, as well as the
Pennsylvania Bar Association and
related organizations.
Physician volunteers from Lehigh
Valley Hospital included Ronald A.
Lutz, M.D., Chairman, Department of

Emergency Medicine; Oscar A.
Morffi, M.D., pediatrician; and
Raymond P. Seckinger, M.D.,
psychiatrist.
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Congratulations!
Sheldon H. Linn, M.D.,
obstetrician/gynecologist, was recently
named a Fellow of the American
College of Obstetricians and
Gynecologists.
Michael Rhodes, M.D., chief of the
Division of Trauma, was recently
elected President of the Eastern
Association for the Surgery of Trauma.
This organization of approximately 500
trauma surgeons throughout the Eastern
United States was designed to furnish
leadership and foster advances in the

surgery of trauma and to afford a
forum for the exchange of knowledge
pertaining to injury control, research,
practice and training in prevention,
care and rehabilitation of injury. The
Journal of Trauma is the official
publication of the Association.

i

Kamalesh T. Shah, M.D.,
general/trauma surgeon, and his wife,
Sunita, recently welcomed their third
son. Aanand was born on January 6
and weighed 4lbs., 6 oz. He has two
brothers, Aakash and Aashay.

Publications, Papers and Presentations
Scott A. Gradwell, D.M.D.,
periodontist, was a guest speaker at a
meeting of the Northampton
Community College Dental Alumni
Association on January 26. His topics
included PSR as Set Forth by the
ADA, Curf'ffage, Root Planning,
Implants.
; Tissue Guidance.
Robert Kricun, M.D., radiologist,
and Lawrence P. Levitt, M.D.,
neurologist, co-authored a paper titled
Tortuous Vertebral Artery Shown by
MR and CT. The article was
published in the September, 1992 issue
of the American Journal of
Roentgenology. It describes the
unusual MR and CT findings of a
tortuous vertebral artery that was
causing pain in the neck and
retroauricular area.
Shantha V. Mathews, M.D.,
neonatologist, co-authored an article
titled Effect of Intrauterine Exposure

tn .~ 'lcaine on Acetylcholinesterase in
Pr · ary Cultures of Fetal Mouse
Br,, d Cells. The article was publishe~
in Volume 14 of Neurotoxicology ant. )
Ter•tology.
Glen L. Oliver, M.D.,
ophthalmologist, attended the Atlantic
Coast Retina Club meeting at Wills
Eye Hospital on January 8, and
presented a paper titled Congenital
Choroid Artery Hypoplasia
associated with Pseudoxanthoma
Elasticum.
A Conservative, Low-Cost
Superovulation Regimen, an article
written by Bruce I. Rose, Ph.D., .
M.D., reproductive endocrinologist
and infertility specialist, was published
in the November/December 1992 issue
of the International Jounuil of
Fertility, Volume 37, No. 6.
Continued on Page 7
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A paper reporting on the incidence of
hemorrhage following colonoscopic
polypectomy at Lehigh Valley Hospital
was recently accepted for publication
by the journal, Diseases of the Colon
& Rectum. The study was authored by
Lester Rosen, M.D., colon-rectal
surgeon; James Reed ill, Ph.D.,
Director of the Department of
Research; Susan Nastasee, Surgical
Editor, Department of Surgery; and
David Bub, medical student from New
York University.

)

This institutional study analyzed 4,721
patients who underwent colonoscopy
and polypectomy from 1987 to 1991 at
Lehigh Valley Hospital and revealed a
significantly low hemorrhage rate of
.4%. These results compared
favorably to 15 published studies that
reported rates ranging from . 3% to
6.1% with an average of 1.9%.
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Upcoming Seminars, Conferences, and Meetings

Medical Grand Rounds
Updates in Systemic Lupus
Erythematosus will be presented by
Steven Berney, M.D., Professor of
Medicine, Department of
Rheumatology, Temple University, on
Tuesday, February 16.
New Controversies of Beta-Agonists
and Use of Anti-inflammatory
Asthma Drugs will be presented by
Howard Israel, M.D., Division of
Allergy, Lehigh Valley Hospital, on
Tuesday, February 23.

Medical Grand Rounds are held on
Tuesday of each week beginning at
noon in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & I-78.
For more information, contact the
Department of Medicine at 402-8200.
Continued on Page 8
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Health Care in the
Second Millennium
The first Stabler-Rex Health Care
Symposium, Health Care in the
Second Millennium, will be held on
Saturday, March 20, from 8:30a.m. to
1 p.m., in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & I-78.
The symposium invites members of the
community concerned with the quality
and delivery of cost-effective health
care to patients in our region.
Speakers will include Thomas W.
Langfitt, M.D., President of the
Glenmede Trust Company and the Pew
Charitable Trusts; Joshua M. Wiener
Ph.D., Senior Fellow at the Brookings
Institution; and John Collins Harvey,
M.D., Ph.D., Senior Research Scholar
at the Center for Clinical Bioethics
'
and Professor of Medicine, Emeritus,
Georgetown University. Their
respective topics are health professions
educatioJ1 reform, health care
rationing, and medical care in a
technological age.
The program is sponsored by the Dr.
John E. Stahler and the Dr. James C.
Rex Endowment Fund in Support of
Surgical Education, Research, and
Development. For more information
'
contact the Department of Surgery at
402-1296.
'

Oncology Programs
The Advanced Oncology Core
Course will be held on March 17, 24,
and 31, from 8 a.m. to 4 p.m., in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & I-78.

This course will be an intensive
educational program designed as a
follow-up to the fundamental oncolog_
core course. It will include oncology
treatment modalities on the horizon
.
'
cutting edge technologies and
communication strategies as applied to
nursing practice. This multidisciplinary approach will include
topics of upcoming interest to nurses
who work in acute care hospitals,
home health agencies, extended care
facilities, private agencies, and
physicians offices.

Coping With Change••• Living With

Loss will be held on March 31 from
7:30a.m. to 3:45p.m., at the Days
Inn Conference Center, Routes 22 &
309, Allentown.

This program will explore issues
related to coping and loss. The crisis
of change will allow you to conduct a
personal assessment of your attitudes
and beliefs about change an4 loss.
Sessions on creative coping will
promote self care by exposing you to
strategies for coping with daily issues.
The afternoon session will focus on
loss as it relates to children and
families.
This program will be of interest to
every level of healthcare worker and
human service provider. Social
workers, nurses, administrators
therapists, pastoral visitors, nur~s'
aides, patient representatives,
psychologists, physicians and interested
others are invited to attend.
For more information on either of
these two programs, please call the
Cancer Center at 402-2582.
)
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Health Promotion Program News
The Health Promotion Program of
Lehigh Valley Hospital will present a
number of free public lectures over the
next few months. Sponsored by the
Chronic Disease Education Committee
of Lehigh Valley Hospital, the lectures
include:

Carpal Tunnel Syndrome will be
presented by Michael A. Chemofsky,
M.D., plastic and reconstructive
surgeon, on Wednesday, February 17,
from 7 to 8:30 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest
& I-78.
The incidence of Carpal Tunnel
Syndrome has reached epidemic
proportions in recent years. The
personal economic impact of this
condition upon society is profound.
Dr. Chemofsky will discuss all aspects
of Carpal Tunnel Syndrome, with
particular emphasis on cause,

• For Sale or Lea.. - Springhouaa Prof...ional
Canter, 1675 Pond Road. Ideal for ph'f8ician'a
office. Approximately 2,500 aq. ft. Will finish
apace to apeclflcatlona.

PHYSICIAN

PRAC'Ia
OPPORTUNmES

• For Sale or Leaae - Madical-profaaaional office
buDding on South Cedar Craat Boulevard, juat
minutaa from Cedar Craat &r. I· 78 and 17th &r. Chaw.
3,680 total aq. ft. Ample parking, aacurlty/fire
alarma inatalled. Ideal for ph'f8ician group.
• For Sale •• Office building at Northeaat corner of
19th and Turner Str..te in Allentown. Upper laval·
2,400 + aq. ft., large welting room, two large
conaultatlon rooma, five exam rooma, ate. Lo-r
laval· 2.300+ aq. ft. Parking lot for 16 care.
• For Le ... - Medical-profaaaional office apace
located on Route 222 in Weacoavilla. Two 1,000
aq. ft. officaa available or combine to form larger
aulta.

)

• For Leaaa •• Medical office apace located In
Southeaat Allentown near Mountainville Shopping
Canter.

prevention, and treatment. The latest
endoscopic techniques will be
presented.

Eat Right America, a special program

to celebrate National Nutrition month,
will be presented on Wednesday,
March 10, from 7 to 8:30p.m., in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & I-78.

Jane Ziegler, M.S., R.D., Director,
Clinical Nutrition Services, will
explain the new Food Guide Pyramid
and how everyone can incorporate
healthy food choices into their lifestyle.
The Health Promotion Program also
offers numerous other classes and
programs for weight control, stress
management, and smoking cessation
which may benefit your patients. For
more information, please call
821-2150.

• For Leaae - Slote are currently available for the
Brown Bag auita at Kutztown Profaaalonal Canter.
• For Leaae •• Share large medical office near Cedar
Craat &r. I· 78. Fully furnished and ataffed. Multiple
line phone •'f8tem. Computerized blUing avaUable.
• For Leaaa - Specialty practice time-ahara apace
available In a comprehanaiva health cera facility.
Rlvaraide Profaaaional Canter. 4019 Wynnewood
Drive, Leur.,. Station. Half- or full-day alote
Immediately available.
• For La•• - Share medical office apace at
Rivaralda Profaaalonal Canter in Leur.,. Station.
Ideal for aolo or email group practice.
• For Leaae - Share apace in MOB 1 on the campua
of Lehigh Valley Hoapltal, Cedar Craat &r. 1-78.
Approximately 1,000 aq. ft. Three exam rooma.
For mora Information or for ...latance In finding
appropriate office apace to meat your naada,
contact Joe Pilla, POPS Rap, at 402-9868.
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WHO'S NEW
The Who's New section of Medical
Stoff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc.
Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff
Appointment
Frank J. Altomare, Jr., MD
(Valley Nuclear Medicine Associates)

5940 Hamilton Blvd.
P.O. Box 3478
Allentown, PA 18106-0478
(215) 398-8141
Department of Radiology/Diagnostic
Medical Imaging
Division of Nuclear Medicine
Provisional Active

Lisa G. Stettner, DO
Lehigh Valley Hospital
Pediatric Clinic
17th & Chew
Allentown, PA 18105-7017
(215) 402-2294
Department of Pediatrics
Division of General Pediatrics
Provisional Limited Duty

Additional Privileges
James Balducci, MD
Department of Obstetrics and
Gynecology
Division of Obstetrics
Section of Maternal-Fetal
Additional Obstetrical Privileges

Kenneth A. Bernhard, MD
Department of Medicine
Division of Cardiology
Interventional Cardiology Privileges
Jeffrey L. Gevirtz, MD
Department of Surgery
Division of Urology
Visual Laser Ablation of the Prostate
(VLAP)

JohnS. Jaffe, MD
Department of Surgery
Division of Urology
Visual Laser Ablation of the Prostate
(VLAP)

Jenni Levy, MD
Department of Medicine
Division of General Internal Medicine
Exercise Treadmill Testing
Edward M. Mullin, Jr., MD
Department of Surgery
Division of Urology
Visual Laser Ablation of the Prostate
(VLAP)

Change of Address
John J. Cassel, MD, PC

John J. Cassel, MD
Jamie D. Paranicas, MD
Jeffrey C. Snyder, MD
1255 S. Cedar Crest Blvd.
Suite 1200
Allentown, PA 18103

Donald P. Goldsmith, MD
Pediatric Rheumatology and Allergy
Department
St. Christopher's Hospital for Children
Front Street at Erie Avenue
Suite 1115
Philadelphia, PA 19134-1095
(215) 427-5094
Continued on Page 11
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Judith L. Ross, MD
Jefferson Medical College
1025 Walnut Street
Suite 700
Philadelphia, P A 19107-6799
(215) 455-1648

Richard H. Snyder, MD
Acting Critical Care Director

Voluntary Relinquishment of
Privileges

Andrea Waxman, MD
Mary T. Zygmunt, DO
1575 Pond Road
Suite 104
Allentown, PA 18104
(215) 398-7848

John A. Mannisi, MD
Department of Medicine
Division of Cardiology
Cardiac Catheterization Privileges

Practice Name Change

Change of Division

Charles L. Knecht m, MD
Charles L. Knecht, MD
3131 College Heights Blvd.
Allentown, PA 18104

Stephen L. Goldman, MD
From Family Practice to Occupational
Medicine

Change of Status
Theodore L. Donmoyer, MD
Department of Medicine
Division of Cardiology
From Active to· Honorary
Robert M. Jaeger, MD
Department of Surgery
Division of Neurosciences·
Section of Neurotrauma
From Emeritus Active to Honorary
Louis E. Spikol, MD
Department of Medicine
Division of Family Practice
From Courtesy to Provisional Active

Appointment of Medical
Directors
Yehia Y. Mishriki, MD

)

Barry H. Slaven, MD.
ICU - 17th & Chew

Chief, Division of Ambulatory Care
(Department of Medicine)

Division Assignments in the
Department of Pathology
Bala B. Carver, MD
Division of Clinical & Anatomic
Pathology
Proctor L. Child, MD
Division of Clinical & Anatomic
Pathology
Malcolm L. Cowen, MD
Division of Forensic Pathology

Elizabeth A. Dellers, MD

Division of Clinical & Anatomic
Pathology

Ronald E. Domen, MD
Division of Clinical & Anatomic
Pathology
William B. Dupree, MD
Division of Clinical & Anatomic
Pathology
Continued on Page 12
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Brian W. Little, MD

Allied Health
Professionals

Theodore J. Matulewicz, MD
Division of Clinical & Anatomic

Appointment

Division of Neurosciences

Pathology

Isidore Mihalakis, MD

Division of Forensic Pathology
Alexander Nedwich, MD
Division of Clinical & Anatomic

Pathology

Raymond A. Rachman, MD
Division of Clinical & Anatomic

P:;; :":lology

w·ayne K. Ross, MD

Division of Neurosciences/Forensic
Pathology
Michael Scarlato, MD

Division of Clinical & Anatomic
Pathology

John A. Abbruzzese

PhD

Associate Scientific
Psychologist
(Department of Psychiatry)

Change of Status and
Additional Privileges
Debra A. Bishwaty, CRNP

Physician Extender
Professional Category - RN to CRNP
(Urologic Associates of Allentown - Mullin)

Termination
Thomas O'Brien, CRNA

Physician Extender
Professional Category- CRNA

(Allentown Anesthesia Associates- Maffeo)

Ralph H. Scott, MD
Division of Clinical & Anatomic

Pathology

John J. Shane, MD

Division of Clinical & Anatomic
Pathology.

)
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Drug Information Bulletin

Editor: Mary Bradley, R.Ph.
Contributors:
Marta Concillo, Phann.O.
& Barbara Petros, Pharm.D.

Pharmacv Department. Februarv. 1993

ADVERSE DRUG REACTIONS
REVISITIED-WE NEED YOUR HELP!

The current Adverse Drug Reaction
(ADR) reporting system has been in place since
November 1991. Initially we observed a transient
increase in the number of reported reactions, but
in the past few months have again regressed to
an average of 20 reports per month.
Every active ADR monitoring system can
be viewed as a vital component of a national
post-marketing drug surveillance system. During
pre-marketing testing, the numbers and nature of
exposed patieots are iosufficient to identify rare
reactioos which ooly occur uoder special
circumstances. For example, as a result of postmarketiog reports of veotricular arrhythmias in
association with Astemizole (Hismaoal ~. the
manufacturer added a boxed warning to their
package information which specifies dose
limitations, warns of use in hepatically impaired
patients and points out the need to discontinue
the drug in patieots experiencing syncope.For this
reason, then, reports of rare or uolabeled
reactions are especially valuable in helping tbe
manufacturer update and communicate
important product information.
In addition to rare and unlabeled
reactions, common drug reactions are important
and need .to be reported. Although commoo
reactions, by definition, occur often, so much so
that they are accepted as the norm, reports of
these reactions may aid in their avoidance in the
future. For eumple, through the reporting of
red-man's syndrome in association with
vancomycin iofusion, it was possible to determine
that this reaction was a direct result of infusion
rate. Consequently, it is now recommended that
the infusion time be at least 60 minutes.
Therefore, if the system is operating effectively,
it is not necessarily individual reactions which
provoke further iovestigation, but rather it is the
frequency and pattern of these kinds of events
that signal the need for closer examination.
For the ADR system to function efficiently, it must be effective in data collection. (NOTE:
It is not important to be convinced prior to
reporting that the suspected drug was implicated
in the untoward event) If reports are
received in a timely manner, appropriate action

can occur more quickly. Should a specific drug
be implicated in producing various reactions,
through the reporting process other individuals
can be spared a similar fate. Since a drug's
safety profile is not static, then, it is only
through increased ADR reporting, that we can
effectively maintain current drug information to
ultimately improve patient care.

DIPYRIDAMOLE (PERSANTINE) FOR
PHARMACOLOGIC S~ TESTING

Dipyridamole (Persantine) has recently
been added to the hospital formulary for use in
pharmacologic stress testing. To date, adenosine
(Adenocard) was the sole agent available for this
use. Both agents are equally safe and effective
with dipyridamole offering a two-fold cost
advantage.
Medta••• of Aetioa: Dipyridamole acts as a
coronary vasodilator by blocking the
transmembrane transport and reuptake of
adenosine, thereby indirectly increasing the _endogenous adenosine plasma levels. The result is a coronary perfusion mismatch in patients with
coronary artery disease.
Dole:
The standard stress testing dose of
dipyridamole is 0.142 mglkg/min given for four
minutes.
The onset of the drug's effect is
apparent within 3-4 minutes with a duration of
efl'ec:t on the cardiovascular system of
approximately 30 minutes.
AdYene effedl:
chest pain, flushing,
hypoteosion, headache, dizziness, nausea, and
epigastric pain.
Alltidote: Aminophylline may be administered to
reverse adverse effects of dipyridamole.
Aminophylline can be administered IV push at SO
mg aliquots over 2 minutes. The usual dosage
range is SO mg to 250 mg.
Proced•re Colllidentioas: The same patient
restrictions and considerations pertain to
dipyridamole as adenosine. The patient must be
NPO for 4-6 hours prior to the procedure. No
xanthine medications (ie. caffeine, caffeinecontaining products ie. Fioricet, theophylline,or
aminophylline) 36 hours prior to the test.
Patients receiving oral dipyridamole (Persantine)
should have all their scheduled doses held for 24
hours pre-procedure.
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SUBLINGUAL NITROGLYCERIN
AVAILABH.JTY:

Recently LVH experienced a nationwide shortage
of Nitroglycerin Sublingual (Nitrostaf') 0.4mg
(1/lSOgr). The product is again available, yet in
limited supply. In the meantime, Nitroglycerin
Sublingual (Nitrostaf') O.lSmg (1/400gr) has been
discontinued by the manufacturer. Alternative
products remaining on formulary include the
alternate strenghts of Nitroglycerin S.L.(eg
0.3mg) and S.L. isosorbide dinitrate.

FORMULARY

Simvastatio ·(Zoco..-)
lsradapioe (Dyaacirc")
latratbecal Lioresal (Baclofea•)

ADDITIONS:

MOVE OVER MEVACOR,
-HERE COMES ZOCOR!

Another HMG CoA reductase inhibitor is now
available for treatment of primary
hypercholesteremia at LVH.
Simvastatin
(ZocorR) by MSD has been shown to be effective
in reducing total and LDL cholesterol.
COMPARATIVE
EFFICACY:
Structurally
similar to lovastatin, this agent possesses greater
potency with regard to inhibition of HMG CoA
reductase production of total cholesterol, LDL,
VLDL , and TG compared to cholestyramine or
probucol. No direct comparative studies with
lovastatin (MevacorR - MSD) have been
performed.
ADVERSE EFFECTS: Similar to those observed
with lovastatin including headache, constipation,
nausea, diarrhea, dizziness, angina and fatigue.
Elevated LFf's from this agent warrant
monitoring of liver function during therapy.
DRUG INTERACI'IONS: Elevated prothrombin
times have occurred with patients receiving
warfarin and increases in serum digoxin levels
have been observed with concomitant therapy.
Rare cases of rhabdomyolysis with acute renal
failure have been reported with simvastatin use
when given with gemfibrozil, cyclosporine,
nicotinic acid or erythromycin.
DOSING: Starting dose of simvastatin are 5lOmg once daily in the evening. The dose range

is 5-40mg!day as a single dose. Dosing
adjustments should be made at intervals of 4
weeks or greater. In the elderly, reduction of
cholesterol may be obtained with 20mg or less.

ANOTHER
BLOCKER?

CALCIUM

CHANNEL

Isradapine (DynacircR) by Sandoz has recently
been added to the LVH formulary. This drug
has been approved for use alone or in
combination with a thiazide diuretic for
treatment of hypertension.
MECHANISM OF ACTION: This
dihydropyridine derivative, similar to nifedipine
or nicardipine, acts as a potent calcium channel
blocker with high · specificity for coronary,
cerebral and skeletal muscle vascular tissue.
Isradapine acts on the SA node but does not
affect conduction through the AV node.
COMPARATIVE EFFICACY: The proposed
advantage of this agent compared to other
calcium channel blockers is the lack of adverse
effects on renal function in the renally impaired
(ie. renal transplant patient). lsradapine appears'"
to possess diuretic and natriuretic effects.
However, there are no direct studies comparing
isradapine to other calcium channel blockers with
regard to these proposed renal effects.
ADVERSE EF'FECTS: The adverse effect profile
of isradapine is similar to other agents within the
class.
Most adverse effects are related to
vasodilatory properties of isradapine such as
headache dizziness, edema, palpitations etc. The
transient increase in heart rate usually subsides
within few weeks of therapy. lsradapine does not
negatively affect cholesterol or triglycerides but
has caused slight increases in serum glucose levels
in diabetic patients.
DRUG INTERACTIONS: None of significance
have been reported
DOSING: The initial dosage is l.Smg BID alone
or in combination with thiazide diuretic.
Maximum response will be seen within 2-4 weeks
of initiation of therapy. The dose may be
increased in increments of Smg/day to maximum
daily use of lOmg. Dosage adjustment in renal
failure does not seem to be necessary. Caution
should be used in the elderly or in patients with
hepatic dysfunction.
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BACK TO BACLOFEN-(INTRATHECAL LIORESAL)

Intrathecal Baclofen has recently been
approved as a muscle relaxant for the
management of patients with refractory spasticity
of the spinal cord and are refractory to oral
therapy. This drug will have limited use due to
the specific patient selection criteria and the
mode of administration.
An implantable
intrathecal pump and catheter need to be placed
for continuous infusion of this medication. The
pump requires refilling every 4-12 weeks. A test
dose is given followed by a titratable infusion.
Patients must be monitored for signs of toxicity
such as dizziness, excessive salivation, nausea,
vomiting and somnolence. High doses have been
associated with loss of consciousness and
respiratory depression. Sudden withdraw) of
Baclofen can lead to a hyperactive state with
uncontrolled spasm, therefore, Baclofen must be
tapered when withdrawn. This drug will not be
routinely stocked in the pharmacy department
due to its lack of clinical urgency.

PARENTERAL ANTIBIOTIC
PRESCRIBING PRACTICES AT LVH

The cost of parenteral antibiotics
in 1992 was approximately 1.57 million dollars at
LVH. Ceftazidime was the number one antibiotic
with respect to cost at both sites. The usage of
ceftazidime also remains high with 55o/o to 80%
of patient's receiving the drug empirically. The
suggested usage guidelines for ceftazidime
recommend its use for aerobic gram-negative
bacilli resistant to cefazolin (ie. Enterobacter or
Serratia) at dosages of 1 GM IV Q8H; and
Pseudomonas aeruginosa at dosages of 2 GM IV
Q8H, when piperacillin is not appropriate
(allergy or resistance).
Intravenous Ciprofloxacin is another
costly antibiotic .with 40% to 60% of its use
being empiric at LVH. It's use should be limited
to resistant aerobic gram-negative bacilli (ie.
Pseudomonas, Enterobacter, Serratia) based on
culture and susceptibility results. Ciprofloxacin,
or any quinolone, should not be used if Staph,
Strep, or an anaerobic infection is suspected.
One approach to empiric therapy for a
suspected gram-negative bacilli infection is to
begin with piperacillin +/- an aminoglycoside. If
Pseudomonas is a concern; the piperacillin dose
should be S GM Q8H plus an aminoglycoside. If

the patient is penicillin allergic, ciprofloxacin or
ceftazidime (if the patient has tolerated
cephalosporins by history) can be used as
alternatives to piperacillin therapy.
The length of empiric therapy is also an
issue of concern at LVH. On average, em pi ric
therapy with an intravenous antibiotic ranges
from 4 to 14 days. Broad-spectrum antibiotic
therapy should be narrowed in 24 to 36 hours
once culture and susceptibility results are
available. Streamlining parenteral therapy to
oral therapy when feasible is another approach to
containing our parenteral antibiotic budget. This
is especially true for intravenous ciprofloxacin.
Ciprofloxacin is rapidly absorbed from the GI
tract after oral administration. Equivalent serum
and tissue concentrations are obtained with both
the oral and intravenous formulations.
An
approximate five-fold cost advantage is apparent
when using the oral over intravenous route of
administration
for ciprofloxacin.
Cost
information regarding any of the other antibiotics
is available upon request from the Clinical
Pharmacy Department at extension 8884.

SERTRALINE

(ZOLOF'r)

USAGE

REYlEW

Sertraline (Zolort• was added to the L VH
Formulary at the May meeting of the Pharmacy
and Therapeutics Committee with the provision
that its use be reviewed in 6 months. Sertraline
use was evaluated in 9 patients on the Psychiatric
Unit at the 17th and Chew St. site using
published criteria. The results are as follows.
All patients received sertraline for the
appropriate indication which is that of major
depressive disorder. Non-compliance was noted
regarding dosage titration and concurrent
antidepressant therapy.
The dosage was
increased more frequently than the recommended
7 day interval in 4 patients. Three patients also
received concurrent use of other antidepressants
(nortriptyline, trazodone). Adverse effects were
noted in 2 patients (tremor, possible exacerbation
of psychotic symptoms). No drug interactions
were observed and M.AOI therapy was not noted
to have been given within 14 days of sertraline
therapy. Sertraline's usage will continue to be
monitored on this unit with the focus being
placed on dosing adjustments and concommitant
antidepressants.

Page 15

LOOK WHAT'S NEW FOR CODE BLUE

The pharmacy department will be
converting six commonly used emergency
medications found on the code carts to a
recessed/needleless syringe in order to provide a
safer means of administering drugs during cod~.
The five drugs include: atropine 1 mg,

epinephrine 1 mg, calcium chloride 1Oo/o,
lidocaine hydrochloride 100 mg, sodium
bicarbonate 50mEq, and dextrose 50%. The
conversion is tentatively scheduled to occur later
this month. Keep your eyes open for posters to
be placed on each nursing unit prior to the '
change.
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